Chemzyme Health Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
- Revenue Growth 35.22%
- Profit Growth -674.39%
- Ebitda 19.18%
- Net Worth -30.38%
- Total Assets 5.40%
About Chemzyme Health Solutions
Chemzyme Health Solutions Private Limited (CHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 August 2012 and has a history of 12 years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Adnaan Shums and Radhika Shums serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101MH2012PTC234520
- Company No.
234520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Chemzyme Health Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adnaan Shums  | Director | 16-Aug-2012 | Current |
| Radhika Shums | Director | 16-Aug-2012 | Current |
Financial Performance of Chemzyme Health Solutions.
Chemzyme Health Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.22% increase. The company also saw a substantial fall in profitability, with a 674.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 30.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemzyme Health Solutions?
In 2021, Chemzyme Health Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2021 | Bank Of India | ₹2.50 M | Open |
How Many Employees Work at Chemzyme Health Solutions?
Unlock and access historical data on people associated with Chemzyme Health Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemzyme Health Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemzyme Health Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
